These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 8640235

  • 1. BRCA2 mutations in primary breast and ovarian cancers.
    Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR, Futreal PA.
    Nat Genet; 1996 Jun; 13(2):238-40. PubMed ID: 8640235
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
    Teng DH, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanwar S, Swedlund B, Wong AK, Kamb A.
    Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
    [Abstract] [Full Text] [Related]

  • 5. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
    Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL.
    Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
    [Abstract] [Full Text] [Related]

  • 6. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.
    Cas Lek Cesk; 2000 Oct 11; 139(20):635-7. PubMed ID: 11192759
    [Abstract] [Full Text] [Related]

  • 7. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.
    Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK.
    Cancer Res; 1996 Aug 01; 56(15):3409-14. PubMed ID: 8758903
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.
    Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.
    Gynecol Oncol; 2000 Sep 01; 78(3 Pt 1):278-87. PubMed ID: 10985881
    [Abstract] [Full Text] [Related]

  • 11. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.
    Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K.
    Nat Genet; 1996 May 01; 13(1):126-8. PubMed ID: 8673092
    [Abstract] [Full Text] [Related]

  • 12. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
    Tsongalis GJ, Linfert DR, Johnson RC, Ackroyd R, Berman MM, Ricci A.
    Arch Pathol Lab Med; 1998 Jun 01; 122(6):548-50. PubMed ID: 9625424
    [Abstract] [Full Text] [Related]

  • 13. Mutation analysis of the BRCA1 gene in ovarian cancers.
    Takahashi H, Behbakht K, McGovern PE, Chiu HC, Couch FJ, Weber BL, Friedman LS, King MC, Furusato M, LiVolsi VA.
    Cancer Res; 1995 Jul 15; 55(14):2998-3002. PubMed ID: 7606717
    [Abstract] [Full Text] [Related]

  • 14. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations.
    Khoo US, Ngan HY, Cheung AN, Chan KY, Lu J, Chan VW, Lau S, Andrulis IL, Ozcelik H.
    Hum Mutat; 2000 Jul 15; 16(1):88-9. PubMed ID: 10874312
    [Abstract] [Full Text] [Related]

  • 15. Mutations of the BRCA1 gene in human cancer.
    Xu CF, Solomon E.
    Semin Cancer Biol; 1996 Feb 15; 7(1):33-40. PubMed ID: 8695765
    [Abstract] [Full Text] [Related]

  • 16. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.
    Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BA, Stratton MR, Easton D.
    Nat Genet; 1997 Jan 15; 15(1):103-5. PubMed ID: 8988179
    [Abstract] [Full Text] [Related]

  • 17. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.
    Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins AM, Dite GS, McCredie MR, Giles GG, Hopper JL, Venter DJ.
    Cancer Res; 1999 Apr 15; 59(8):2011-7. PubMed ID: 10213514
    [Abstract] [Full Text] [Related]

  • 18. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
    Ingvarsson S, Agnarsson BA, Sigbjornsdottir BI, Kononen J, Kallioniemi OP, Barkardottir RB, Kovatich AJ, Schwarting R, Hauck WW, Huebner K, McCue PA.
    Cancer Res; 1999 Jun 01; 59(11):2682-9. PubMed ID: 10363992
    [Abstract] [Full Text] [Related]

  • 19. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Australian Ovarian Cancer Study Management Group.
    J Natl Cancer Inst; 2008 Nov 05; 100(21):1519-29. PubMed ID: 18957670
    [Abstract] [Full Text] [Related]

  • 20. Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families.
    Vaziri SA, Krumroy LM, Rostai M, Casey G.
    Hum Mutat; 2001 Nov 05; 17(1):74. PubMed ID: 11139249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.